Author: Peter

Local nonprofit Cure 4 the Kids Foundation announced...the creation of the first outpatient palliative care clinic specifically for children in Nevada...The Pediatric Palliative Care Clinic, which is supported by Cure 4 the Kids, debuted last month in Las Vegas at the Children's Specialty Center of Nevada... Having a child with complex medical issues is often overwhelming for parents and these special kids. The palliative program will offer the child and family the support they need...It focuses on providing relief to the symptoms of serious conditions such as cancer and genetic disorders whether or not the affected person is still seeking treatment...The center's services aren't akin to immediate end-of-life care...Instead, children affected by what the center calls "life-limiting" diseases will receive care without having to be admitted to the hospital...Although the cost of care may be covered by a family's major medical benefits, the services will be provided regardless of a family's ability to pay...

A new health care quality standard has been released to help protect both care providers and patients...The updated United States Pharmacopeia-National Formulary includes a new general chapter, <800> Hazardous Drugs – Handling in Healthcare Settings, to decrease the risk of residual exposure to potentially dangerous medications...USP <800> applies to physicians, nurses, veterinarians, pharmacists, and technicians in health care facilities that handle or store hazardous drugs to prevent and limit exposure... This new standard developed by the USP Compounding Expert Committee, which builds upon other prior publications, included insight from a panel of medical industry experts. The panel helped guide best practices, different techniques, engineering controls, and other elements for handling hazardous drugs...

Bowing to pressure from lawmakers, Dr. Robert Califf...nominee to lead the Food and Drug Administration, said on Thursday the agency would reform its process for approving opioid painkillers...Last month Democratic Senator Edward Markey of Massachusetts placed a hold on Califf's nomination, preventing it from being voted on by the full Senate, until the agency agreed to convene an advisory panel to review future opioid approval decisions...The FDA said it has agreed

• ...to convene a committee before approving any new opioid that does not have abuse-deterrent properties. And it said the agency's pediatric advisory committee will make recommendations before any new labeling relating to children is approved.
• ...develop additional safety information for immediate-release opioid painkillers; strengthen the requirement for drugmakers to produce information after a drug reaches the market; and expand access to abuse-deterrent opioid drug formulations.
• ...considering making naloxone...accessible over the counter to treat opioid overdose.

Lately, the spotlight has turned on Valeant and Turing Pharmaceuticals when it comes to the drug-pricing debate. But the price-hiking strategy goes far, far beyond that pair of drugmakers...A survey of roughly 3,000 brand-name prescription treatments has found that prices more than doubled on 60 of them since December 2014...And they've more than quadrupled on 20 of the medications over that same timeframe...The data shows that price increases are an integral part of the business plan... The Wall Street Journal pointed to a slew of Big Pharma moneymakers that owed part of their success to hefty price increases...And while Valeant has pledged to nix most of its planned price increases this year, recent political pushback and public scrutiny haven't convinced some of its peers to do away with the practice...As drugmakers have argued, boosting their list prices doesn't mean necessarily boosting their bottom lines all that much. Insurers and health plans negotiate discounts, meaning pharma companies don't reap the entire increase. Still...a higher starting point for negotiations helps them end up at a higher finishing point...Even if they don't get all of that price increase, they will get some of it...

Health officials say a disease believed to have caused a major increase in birth defects among Brazilian-born babies is unlikely to flourish in Nevada, though travelers could bring it to the state...As of Thursday, 31 cases of Zika virus disease have been confirmed in the United States, but all are related to travel outside of the country, Southern Nevada Health District Disease Investigation and Intervention Specialist Tony Fredrick said. There are no known cases in Nevada...Travel could bring infected people from these regions to the Silver State, said James M. Wilson, director of the Nevada State Infectious Disease Forecast Station at the University of Nevada, Reno...Trapping efforts in Southern Nevada have not shown any sign of the Aedes species of mosquito, which is believed to have been the primary cause of most recent infections...

Alabama recently executed its first inmate using a 3-drug cocktail containing midazolam in place of the more commonly used pentobarbital...This is because compounding pharmacies in Alabama were not willing to make pentobarbital for lethal injection...Four other states’ pharmacies also declined to compound pentobarbital for the Alabama Department of Corrections...Both the International Academy of Compounding Pharmacists and the American Pharmacists Association have issued statements discouraging pharmacists from participation in executions...IACP said compounding lethal injection drugs goes against pharmacists’ focus on healing and care. It also pointed out that state boards of pharmacy could potentially seek ramifications against a pharmacy that knowingly prepares a drug that will cause harm...With manufacturers and compounding pharmacies’ resistance, state departments of corrections may have to turn to alternative methods for executions...in April 2015, Oklahoma approved the use of nitrogen hypoxia in a gas chamber if the state could not obtain lethal injection drugs...In Utah, Governor Gary Herbert signed a law in March 2015 that allows for the use of a firing squad as a plan B.

 U.K. drug store Boots has bowed to pressure and cut the prices on some of its products after it emerged it was charging women more than men for similar products...An online petition started two weeks ago raised awareness of the price discrepancy between some of Boots' products. An eye cream for men cost £7.29 ($10.56) but the same product advertised to women cost £9.99 ($14.47). Meanwhile, a pack of 10 disposable razors for men cost £1.49, but a pack of eight razors for women costs £2.29...Boots said it conducted a review after the issue was brought to light and has taken action to correct the prices of its own-brand products. It also said it would speak to its suppliers and ask them to conduct a similar review of their brands..."At Boots UK, we have never operated a pricing system that discriminates against women so we were surprised and disappointed to see recent examples in the press that did not reflect our own standards,"...

Michael Zeglinski, vice president of Specialty Pharmacy Operations at BriovaRx, discusses how expensive hepatitis C drugs have impacted the specialty landscape. (video)

...independent pharmacies have demonstrated tremendous market resiliency by offering patient-oriented amenities, niche marketing, and above all, customer service... With proper planning and direction, great staff, and tireless effort, a financially viable community pharmacy will be poised to stay put in the neighborhood for years to come...but what about the community hospital outpatient pharmacy? This pharmacy is usually located in a medical office building on the hospital campus...Our store has done well by serving the hospital employee population, the physicians from surrounding offices and their families, a local retirement facility, and many folks who drive past local big-box pharmacies just to come to our little store...no amount of service can overcome the decreasing insurance reimbursement in this competitive prescription medication marketplace. As a result, the survival of the community hospital outpatient pharmacy depends on its ability to make itself indispensable to the hospital it is associated with...Here are 6 things that an outpatient pharmacy can do to help maintain alignment with its associated hospital:

1. Make sure that the pharmacy’s hours of operation align with the peak discharge hours of the hospital and emergency room.
2. Create and maintain an open line of communication with the nursing staff, especially from the emergency room and telemetry units.
3. Make sure that the inpatient pharmacists are detailing and promoting the outpatient pharmacy services at every opportunity.
4. Ask to participate in the weekly or monthly readmission campaign meetings...How can the outpatient pharmacy participate and help meet readmission goals?
5. ...meet with the nurse case managers and social workers. We all know about the importance of medication adherence...How can the outpatient pharmacy help the discharge planning team facilitate getting the discharge prescriptions filled...
6. Begin a discussion with the hospital’s pharmacy director to create a plan that details what opportunities the outpatient pharmacy may have to help increase Hospital Consumer Assessment of Healthcare Provider and Systems...

CRISPR/Cas9 gene editing is a rapidly developing technique that is thought to provide revolutionary new ways to manipulate genes for the treatment of a number of diseases. Delivering the CRISPR therapeutic in an efficient, safe and predictable way, though, has been difficult--to this end, researchers at UMass have created a means of administering the gene editor that could help send it to clinical trials...CRISPR/Cas9 is a natural immune system in bacteria used to protect them from foreign genetic material, and scientists have used its components to cut and repair DNA sequences to replace faulty, disease-causing portions with corrected versions...The difficulty comes about in getting the separate components to the genetic material in a target cell. Previous attempts at delivering the system through disruptive, high-powered injection has caused damage to the liver...The new delivery method involves a two-part process. The researchers loaded both the CRISPR guide RNA and the DNA template into a viral vector...A week after the first injection, the scientists deliver the Cas9 messenger RNA wrapped in lipid nanoparticles...Until now it's not been possible to deliver CRISPR/Cas9 in a way that was suitable for clinical trials. By using an RNA guide and DNA repair template delivered via viral vector followed by a Cas9 in a lipid nanoparticle, we've take a huge step forward to overcoming this hurdle.